Rafferty Asset Management
DXCM icon

Rafferty Asset Management’s DexCom DXCM Stock Holding History

Rafferty Asset Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.5M Buy
230,257
+30,428
+15% +$2.03M 0.04% 211
2026
Q1 		$12.5M Sell
199,829
-27,840
-12% -$1.94M 0.05% 208
2025
Q4 		$15.1M Buy
227,669
+2,636
+1% +$170K 0.05% 208
2025
Q3 		$15.1M Buy
225,033
+36,347
+19% +$2.88M 0.05% 213
2025
Q2 		$16.5M Sell
188,686
-19,553
-9% -$1.53M 0.05% 178
2025
Q1 		$14.2M Buy
208,239
+3,380
+2% +$276K 0.06% 194
2024
Q4 		$15.9M Sell
204,859
-2,427
-1% -$180K 0.06% 194
2024
Q3 		$13.9M Buy
207,286
+57,508
+38% +$4.72M 0.05% 229
2024
Q2 		$17M Buy
149,778
+14,548
+11% +$1.84M 0.06% 172
2024
Q1 		$18.8M Buy
135,230
+7,641
+6% +$960K 0.07% 157
2023
Q4 		$15.8M Sell
127,589
-387
-0.3% -$39.5K 0.07% 174
2023
Q3 		$11.9M Buy
127,976
+32,941
+35% +$3.71M 0.07% 177
2023
Q2 		$12.2M Buy
95,035
+10,084
+12% +$1.22M 0.07% 170
2023
Q1 		$9.87M Buy
84,951
+9,255
+12% +$1.04M 0.07% 185
2022
Q4 		$8.57M Sell
75,696
-26,424
-26% -$2.9M 0.07% 230
2022
Q3 		$8.22M Sell
102,120
-6,384
-6% -$541K 0.09% 175
2022
Q2 		$8.09M Buy
108,504
+35,472
+49% +$3.24M 0.07% 181
2022
Q1 		$9.34M Buy
73,032
+30,320
+71% +$3.32M 0.06% 208
2021
Q4 		$5.73M Sell
42,712
-5,028
-11% -$722K 0.03% 326
2021
Q3 		$6.53M Buy
47,740
+4,740
+11% +$598K 0.04% 245
2021
Q2 		$4.59M Sell
43,000
-5,548
-11% -$533K 0.03% 341
2021
Q1 		$4.36M Buy
48,548
+888
+2% +$83.4K 0.03% 313
2020
Q4 		$4.41M Buy
47,660
+12,188
+34% +$1.09M 0.04% 244
2020
Q3 		$3.66M Sell
35,472
-296
-0.8% -$30.9K 0.04% 235
2020
Q2 		$3.63M Buy
+35,768
New +$3.2M 0.05% 232
2020
Q1 		– Sell
-6,492
Closed -$355K – 657
2019
Q4 		$355K Sell
6,492
-3,452
-35% -$164K 0.01% 754
2019
Q3 		$371K Sell
9,944
-6,476
-39% -$252K 0.01% 725
2019
Q2 		$615K Buy
+16,420
New +$516K 0.01% 643

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Rafferty Asset Management's DXCM Position: Q2 2026 in Review

Rafferty Asset Management increased its DexCom (DXCM) stake by 15% in Q2 2026, buying an estimated $2.03M and bringing the position to 230,257 shares worth $15.5M. The position accounts for 0.04% of the portfolio, ranked #211.

Rafferty Asset Management first reported a position in DXCM in Q2 2019 and has held it in 28 quarters since. The position peaked at $18.8M in Q1 2024. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Rafferty Asset Management held 230,257 shares of DexCom worth $15.5M as of Q2 2026.
  • Rafferty Asset Management bought 30,428 DexCom shares in Q2 2026, an estimated $2.03M.
  • DexCom made up 0.04% of Rafferty Asset Management's portfolio in Q2 2026, its #211 holding.
  • Rafferty Asset Management first reported a position in DexCom in Q2 2019 and has held it in 28 quarters since.
  • Rafferty Asset Management's DexCom position peaked at $18.8M in Q1 2024.
  • 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Rafferty Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.